. Author manuscript; available in PMC: 2022 Sep 1.

Published in final edited form as: Transplant Cell Ther. 2021 Jun 18;27(9):770.e1–770.e7. doi: 10.1016/j.jtct.2021.06.016

Table 2-.

Stem cell mobilization outcomes

Variable	Chemo-mobilized Cohort N=117	Matched cohort N=117	P value
Apheresis collections, median (range)	2 (1–8)	2 (1–8)	0.9
Plexifor use, n (%)	34 (29)	77 (65)	<0.001
Total CD34 stem cell collected, ×10⁶ cells/kg (range)	10.7 (7.95–13.73)	8.77 (6.27–11.2)	<0.001
CD34 stem cell dose infused, ×10⁶ cells/kg (range)	4.38 (1.79–14.9)	3.89 (2.42–11.2)	0.0008
Side effects during mobilization	23 (20%)	0
More than one side effect during mobilization	5 (4.2%)	0
Admission due to adverse events during mobilization	10 (9%)	0

n=number; IQR=interquartile range.